Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 19Prostatic Neoplasms 9Polycystic Ovary Syndrome 7Vitamin D Deficiency 6Osteoporosis 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasms 4Colonic Neoplasms 4Obesity 3Inflammation 3Colorectal Neoplasms 3Bone Diseases, Metabolic 3Neoplasm Metastasis 2Multiple Endocrine Neoplasia Type 1 2Motor Activity 2Lymphoma 2Lung Neoplasms 2Leukemia 2Gastrointestinal Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Hepatocellular 2Brain Neoplasms 2Warts 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Solid Cancers 1

Interventions

Metformin 28Exercise 8Pioglitazone 7Inositol 6Insulin 5Acupuncture Therapy 4High-Intensity Interval Training 3Ethinyl Estradiol 3salicylsalicylic acid 2drospirenone and ethinyl estradiol combination 2Water 2Tablets 2Surveys and Questionnaires 2Sugars 2Resistance Training 2Folic Acid 2Diet Therapy 2Cyproterone Acetate 2Caloric Restriction 2ziprasidone 1maltodextrin 1lime 1exendin (9-39) 1drospirenone 1cinnulin PF 1adrenosterone 1World Health Organization oral rehydration solution 1Waist-Hip Ratio 1Waist Circumference 1Vitamin D 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Insulin Resistance × Vitamin D × Clear all
NCT00907153 2017-12-19

Vitamin D for the Treatment of Women With Polycystic Ovary Syndrome (PCOS)

Milton S. Hershey Medical Center

Phase 1/2 Completed
36 enrolled 44 charts

Inflammation, Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡